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Methods 
Survey: 
• A survey was distributed to 280 PCPs throughout VT 
by email or fax; 63 surveys were completed. 
• 19 multiple choice questions assessed practices and 
attitudes relating to the screening, early detection, and 
diagnosis of AD and dementia. 
• Data was analyzed using Microsoft Excel. 
 
Focus Group: 
• Patients with AD and other forms of dementia, and 
their caregivers, attended a 2-hour focus group. 
• 13 participants provided their perspectives on the 
benefit and/or harm of early detection of AD and 
dementia and shared their personal experiences. 
 
 
Conclusion 
• The USPSTF statement that there is insufficient 
evidence to recommend routine screening for dementia 
has caused controversy in the medical community. 
• We have found that PCPs in VT are reluctant to 
routinely screen for AD and dementia, in large part due 
to the perception that early diagnosis of AD in the 
absence of a cure serves no purpose. 
• Our interactions with patients and their caregivers  
taught us that experiencing cognitive decline without a 
diagnosis is extraordinarily distressing; the diagnosis 
itself facilitates acceptance of a “new normal” and 
enables adaptation to life with AD or other dementia.   
• We conclude that screening and early intervention for 
AD and dementia are extremely important.  We 
encourage PCPs to be proactive in screening so that 
patients can plan, and maintain quality of life, prior to 
the onset of late-stage disease. 
 
 
Introduction 
• Alzheimer’s Disease (AD) is a form of progressive 
dementia that affects 5.3 million Americans and is the 
sixth leading cause of death in the US.   
• Age is a major risk factor for disease , and 1 in 8 
Americans over 65 can expect to develop AD.   
• The U.S. healthcare system spends $172 billion/year on 
patients with AD and dementia, more than half of the 
Medicare budget.  This cost is estimated to increase to 
over $1 trillion by 2050. 
• In 2003, the US Preventative Services Task Force 
(USPSTF) concluded that screening older adults for 
dementia is ineffective due to insufficient means of 
preventing or slowing its progression. 
• In 2011, the National Institute on Aging published new 
diagnostic criteria for AD. 
• In accordance with these guidelines the Centers for 
Medicare and Medicaid Services released rules for the 
new Annual Wellness Visit that include the detection of 
cognitive impairment.   
• Our goal was to identify the attitudes and practices of 
primary care physicians (PCPs) in Vermont (VT) 
related to screening for AD and dementia. 
 
 
Discussion 
• 78% of PCPs believe that there are reasons why early 
detection of AD is not important; of those, 87%  cite no 
effective treatment or cure as the main reason. Those 
94% of PCPs who think that it can be important believe 
that the most important reason for early detection is to 
provide support and resources for the patient and 
family. 
• Focus group members felt that regardless of a cure, a 
diagnosis is essential in order to learn about and find 
ways to live happily with their disease, and stressed the 
importance of an early diagnosis in initiating support 
groups and family planning. 
• While the most common reason why physicians don’t 
always screen for AD is due to other medical issues that 
are more pressing, caregivers and patients believe that 
cognitive status should be addressed in every 
appointment because it’s an everyday struggle. 
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Results 
“The medical 
establishment doesn’t 
think it makes a difference 
in terms of medication, 
but it makes a difference 
to the patient. I didn’t 
know what was wrong, 
and that was scary. 
Having the diagnosis was 
a big help for me, 
personally.” 
- Focus Group Participant 
“Even if they don’t have a 
lot of medication for me, I 
can make a new normal. 
Adjusting to that is what I 
need to do, not focus on 
what I can’t do….One 
piece of information can 
make the difference in a 
family’s whole life” 
- Focus Group Participant 
*Participants could select more than one answer 
*Participants could select more than one answer 
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